Memantine for Prevention of Brain Irradiation-Induced Cognitive Toxicity: A Tale of an Underappreciated and Underused Intervention
Open Access
- 1 September 2020
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 6 (6), 1384-1388
- https://doi.org/10.1200/GO.20.00342
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- A pilot study using dynamic contrast enhanced-MRI as a response biomarker of the radioprotective effect of memantine in patients receiving whole brain radiotherapyOncotarget, 2016
- Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade GliomaThe New England Journal of Medicine, 2016
- Donepezil for Irradiated Brain Tumor Survivors: A Phase III Randomized Placebo-Controlled Clinical TrialJournal of Clinical Oncology, 2015
- Phase II double-blind placebo-controlled randomized study of armodafinil for brain radiation-induced fatigueNeuro-Oncology, 2015
- Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional TrialJournal of Clinical Oncology, 2014
- Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trialNeuro-Oncology, 2013
- Molecular Pathways: Radiation-Induced Cognitive ImpairmentClinical Cancer Research, 2013
- A Phase III, Double-Blind, Placebo-Controlled Prospective Randomized Clinical Trial of d-Threo-Methylphenidate HCl in Brain Tumor Patients Receiving Radiation TherapyInternational Journal of Radiation Oncology*Biology*Physics, 2007
- Memantine in Moderate-to-Severe Alzheimer's DiseaseThe New England Journal of Medicine, 2003
- Methylphenidate therapy improves cognition, mood, and function of brain tumor patients.Journal of Clinical Oncology, 1998